Clinical trial
Screening for Cardiac and Cardiac-associated Pathology Using Single-channel Electrocardiogram Analyzed With Machine Learning Models
NCT07396792 is registered in ClinicalTrials.gov with I.M. Sechenov First Moscow State Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Screening for Cardiac and Cardiac-associated Pathology Using Single-channel Electrocardiogram Analyzed With Machine Learning Models
- Lead sponsor
- I.M. Sechenov First Moscow State Medical University
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- April 1, 2026
- Completion date
- May 13, 2028
- Enrollment
- 4,000 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
arterial hypertension, chronic kidney disease (stage 3-4), coronary artery disease, diabetes mellitus, heart failure, heart rhythm disorders, metabolic syndrome, valvular heart diseases